Novel Biocompatible Disease Modifying Nanomedicine of VIP for Rheumatoid Arthritis Publication Novel Biocompatible Disease Modifying Nanomedicine of VIP for Rheumatoid Arthritis Despite advances in rheumatoid arthritis (RA) treatment, efficacious and safe disease-modifying therapy still represents an…CertaraDecember 4, 2012
What Can We Learn from a Human Mass Balance Study? Knowledge Base What Can We Learn from a Human Mass Balance Study? Mass balance studies are also called “C-14 studies” or “Absorption, Metabolism, and Excretion (AME) studies”.…CertaraNovember 27, 2012
Bioavailability BlogKnowledge Base Bioavailability Discover bioavailability in pharmacokinetics, its types, the first-pass effect, and calculations. Explore tools for accurate…CertaraNovember 4, 2012
Simulations Using a Drug-disease Modeling Framework and Phase 2 Data Predict Phase 3 Survival Outcome in First-line Non-small Cell Lung Cancer Publication Simulations Using a Drug-disease Modeling Framework and Phase 2 Data Predict Phase 3 Survival Outcome in First-line Non-small Cell Lung Cancer Simulations were performed for carboplatin/paclitaxel (C/P) plus motesanib or bevacizumab vs. C/P as first-line treatment…CertaraNovember 1, 2012
Characterization of Exposure Versus Response of Edoxaban in Patients Undergoing Total Hip Replacement Surgery Publication Characterization of Exposure Versus Response of Edoxaban in Patients Undergoing Total Hip Replacement Surgery Edoxaban is an oral direct factor Xa inhibitor approved for the prevention of venous thromboembolism…CertaraNovember 1, 2012
Designing a Clinical Drug-drug Interaction Study Knowledge Base Designing a Clinical Drug-drug Interaction Study After a much longer delay that I expected, I am back to blogging on a…CertaraOctober 29, 2012
Microdialysis Evaluation of Clozapine and N-desmethylclozapine Pharmacokinetics in Rat Brain Publication Microdialysis Evaluation of Clozapine and N-desmethylclozapine Pharmacokinetics in Rat Brain A significant barrier to realization of the full potential of clozapine as a therapeutic agent…CertaraOctober 1, 2012
In Vivo-formed Versus Preformed Metabolite Kinetics of Trans-resveratrol-3-sulfate and Trans-resveratrol-3-glucuronide Publication In Vivo-formed Versus Preformed Metabolite Kinetics of Trans-resveratrol-3-sulfate and Trans-resveratrol-3-glucuronide Metabolites in safety testing have gained a lot of attention recently. Regulatory agencies have suggested…CertaraOctober 1, 2012
Relationship Between Prenatal Exposure to Polychlorinated Biphenyls and Birth Weight: A Systematic Analysis of Published Epidemiological Studies Through a Standardization of Biomonitoring Data Publication Relationship Between Prenatal Exposure to Polychlorinated Biphenyls and Birth Weight: A Systematic Analysis of Published Epidemiological Studies Through a Standardization of Biomonitoring Data Impact of prenatal PCB exposure on birth weight was investigated in various children cohorts and…CertaraOctober 1, 2012
Phenanthrene Metabolism in Smokers: Use of a Two-step Diagnostic Plot Approach to Identify Subjects with Extensive Metabolic Activation Publication Phenanthrene Metabolism in Smokers: Use of a Two-step Diagnostic Plot Approach to Identify Subjects with Extensive Metabolic Activation Polycyclic aromatic hydrocarbons (PAHs) in cigarette smoke are among the most likely causes of lung…CertaraSeptember 1, 2012